Queen’s speech trails gene-editing innovation bill
11-05-2022
WHO launches genome editing registry
03-09-2019
Russian scientist pledges to make more CRISPR-edited babies
12-06-2019
Vchal / Shutterstock.com
An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
gene editing, genomes, human gene editing, regulations, CRISPR, Sangamo Therapeutics, CRISPR Therapeutics, Alliance for Regenerative Medicine, Editas
